...
首页> 外文期刊>Journal of Molecular Biology >Antiparallel beta-Sheet Structure within the C-Terminal Region of 42-Residue Alzheimer's Amyloid-beta Peptides When They Form 150-kDa Oligomers
【24h】

Antiparallel beta-Sheet Structure within the C-Terminal Region of 42-Residue Alzheimer's Amyloid-beta Peptides When They Form 150-kDa Oligomers

机译:当形成150-KDA低聚物时,在42-残基阿尔茨海默蛋白蛋白β肽的C末端区域内反平行β-片状结构

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Understanding the molecular structures of amyloid-beta (A beta) oligomers and underlying assembly pathways will advance our understanding of Alzheimer's disease (AD) at the molecular level. This understanding could contribute to disease prevention, diagnosis, and treatment strategies, as oligomers play a central role in AD pathology. We have recently presented a procedure for production of 150-kDa oligomeric samples of A beta(1-42) (the 42-residue variant of the A beta peptide) that are compatible with solid-state nuclear magnetic resonance (NMR) analysis, and we have shown that these oligomers and amyloid fibrils differ in intermolecular arrangement of beta-strands. Here we report new solid-state NMR constraints that indicate antiparallel intermolecular alignment of beta-strands within the oligomers. Specifically, 150-kDa A beta(1-42) oligomers with uniform C-13 and N-15 isotopic labels at 132, M35, G37, and V40 exhibit beta-strand secondary chemical shifts in 2-dimensional (2D) finite-pulse radiofrequency-driven recoupling NMR spectra, spatial proximities between 132 and V40 as well as between M35 and G37 in 2D dipolar-assisted rotational resonance spectra, and close proximity between M35 H-alpha and G37 H-alpha in 2D CHHC spectra. Furthermore, 2D dipolar-assisted rotational resonance analysis of an oligomer sample prepared with 30% labeled peptide indicates that the 132-V40 and M35-G37 contacts are between residues on different molecules. We employ molecular modeling to compare the newly derived experimental constraints with previously proposed geometries for arrangement of A beta molecules into oligomers. (C) 2015 Elsevier Ltd. All rights reserved.
机译:理解淀粉样蛋白β(β)低聚物和底层组装途径的分子结构将推进我们对分子水平的阿尔茨海默病(AD)的理解。这种理解可以促进疾病预防,诊断和治疗策略,因为低聚物在广告病理学中发挥着核心作用。最近我们介绍了制备150-KDA低聚样品的β(1-42)(β肽的42-残基变体)的方法,其与固态核磁共振(NMR)分析相容,以及我们已经表明,这些低聚物和淀粉样蛋白原纤维在β-股的分子间排列中​​不同。在这里,我们报告了新的固态NMR约束,表示低聚物内β链的反平行分子间对准。具体地,在132,M35,G37和V40处具有均匀的C-13和N-15同位素标记的150kDaαβ(1-42)低聚物在二维(2D)有限脉冲中表现出β-股二级化学位移射频驱动的循环释放NMR光谱,132和V40之间的空间邻近,在2D双极辅助旋转谐振谱中的M35和G37之间,在2D CHHC光谱中靠近M35 H-α和G37 H-α之间的接近。此外,用30%标记的肽制备的低聚物样品的2D偶极辅助旋转共振分析表明,132-V40和M35-G37触点在于不同分子的残基之间。我们采用分子建模来比较新衍生的实验约束,以便将β分子布置成低聚物的预先提出的几何形状。 (c)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号